Immunization with a recombinant bacillus Calmette-Guerin strain confers protective Th1 immunity against the human...

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• Human metapneumovirus (hMPV) causes significant childhood respiratory illness and reinfection due to poor immune memory.
• hMPV infection can trigger an inadequate Th2 immune response, leading to severe lung inflammation and airway obstruction.
• Effective hMPV clearance likely requires a balanced Th1 immune response, characterized by IFN-γ-secreting T cells.

Purpose of the Study:

• To investigate the potential of recombinant bacillus Calmette-Guérin (rBCG) expressing hMPV antigens as a vaccine candidate.
• To evaluate if rBCG immunization can induce protective Th1 immunity against hMPV infection.

Main Methods:

• Mice were immunized with rBCG strains engineered to express the hMPV phosphoprotein.
• Immunized mice were subsequently challenged with hMPV to assess protection against disease.
• T cell responses, including IFN-γ and IL-2 production, were analyzed in immunized mice.
• Adoptive transfer of hMPV-specific T cells was performed to confirm their protective capacity.

Main Results:

• Mice immunized with rBCG expressing hMPV antigens showed protection against weight loss, lung inflammation, and viral replication post-hMPV infection.
• The rBCG vaccine induced hMPV-specific T cells producing key Th1 cytokines, IFN-γ and IL-2.
• Adoptive transfer of these activated T cells conferred protection against hMPV infection in recipient mice.

Conclusions:

• rBCG expressing hMPV antigens effectively induces protective Th1 immunity.
• This rBCG-based vaccine strategy shows significant potential for preventing hMPV infections.
• The findings support the consideration of rBCG as an efficient vaccine against hMPV.